Wolman Disease: Clinical Trials

3 trials for Wolman Disease, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 recruiting. 3 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 13Completed 2, Recruiting 1
Phase 21Completed 1

Follow Wolman Disease: new trials by email Literature Review of Wolman Disease trials Research Report on Wolman Disease

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
PEARL (PrEnAtal Enzyme Replacement Therapy for Lysosomal Storage Disorders)
Aldurazyme (laronidase) - MPS I, MPS II
Phase 1RecruitingUniversity of California, San Francisco102021-07-012026-03-17
Human Placental-Derived Stem Cell Transplantation
Human Placental Derived Stem Cell - Mucopolysaccharidosis I, Mucopolysaccharidosis VI
Phase 1CompletedNew York Medical College432013-04-012022-10-25
Safety, Tolerability and Pharmacokinetics of SBC-102 (Sebelipase Alfa) in Adult Participants With Lysosomal Acid Lipase Deficiency
Sebelipase alfa 0.35 mg/kg, Sebelipase alfa 1 mg/kg, Sebelipase alfa 3 mg/kg - Cholesterol Ester Storage Disease(CESD), Lysosomal Acid Lipase Deficiency
Phase 1 / Phase 2CompletedAlexion Pharmaceuticals, Inc.92011-04-252018-12-11

Narrower conditions

Gaucher Disease (2)  ·  Mucopolysaccharidosis VI (2)  ·  Adrenoleukodystrophy (1)  ·  Anemia, Aplastic (1)  ·  Anemia, Diamond-Blackfan (1)  ·  Cholesterol Ester Storage Disease (1)  ·  Fucosidosis (1)  ·  Leukemia, Myeloid, Acute (1)  ·  Leukodystrophy, Globoid Cell (1)  ·  Leukodystrophy, Metachromatic (1)  ·  Lysosomal Storage Diseases (1)  ·  Metabolism, Inborn Errors (1)  ·  Mucopolysaccharidosis I (1)  ·  Mucopolysaccharidosis IV (1)

Broader conditions

Congenital, Hereditary, and Neonatal Diseases and Abnormalities (3)  ·  Genetic Diseases, Inborn (3)  ·  Infant, Newborn, Diseases (3)  ·  Lipid Metabolism Disorders (3)  ·  Lipid Metabolism, Inborn Errors (3)  ·  Lipidoses (3)  ·  Metabolic Diseases (3)  ·  Nutritional and Metabolic Diseases (3)  ·  Brain Diseases (2)  ·  Brain Diseases, Metabolic (2)  ·  Brain Diseases, Metabolic, Inborn (2)  ·  Carbohydrate Metabolism, Inborn Errors (2)  ·  Central Nervous System Diseases (2)  ·  Cholesterol Ester Storage Disease (2)  ·  Connective Tissue Diseases (2)

Interventions

Sebelipase alfa (2)  ·  GAA protein, human (1)  ·  GALNS protein, human (1)  ·  Iduronidase (1)  ·  galsulfase (1)  ·  idursulfase (1)  ·  vestronidase alfa (1)

Sponsors

Alexion Pharmaceuticals, Inc. (1)  ·  New York Medical College (1)  ·  University of California, San Francisco (1)

Countries

United States (3)  ·  Czechia (1)  ·  France (1)  ·  United Kingdom (1)

Top investigators

Mitchell S Cairo, MD (1)  ·  Tippi MacKenzie, MD (1)

Results publications

PMID 15324318, PMID 19948615, PMID 21637107, PMID 23348766, PMID 23510062, PMID 28374935, PMID 28657663, PMID 30337566, PMID 32102934, PMID 37955580, PMID 39891377, PMID 9918480